Glycolytic enzymes such as LDHA, PKM2, HK2, and ENO1, along with nutrient transporters like GLUT1, ASCT2, and LAT1, are consistently upregulated across multiple cancer types and have been linked to poor prognosis and therapy resistance. This evidence concerns the gene SLC1A5 and cancer.